Cholangiocarcinoma arising in Von Meyenburg complex associated with hepatocellular carcinoma in genetic haemochromatosis

被引:20
作者
Blanc, JF [1 ]
Bernard, PH [1 ]
Carles, J [1 ]
Le Bail, B [1 ]
Balabaud, C [1 ]
Bioulac-Sage, P [1 ]
机构
[1] Hop St Andre, Federat Hepatogastroenterol, Bordeaux, France
关键词
cholangiocarcinoma; haemochromatosis; hepatocellular carcinoma; reversibility of cirrhosis; Von Meyenburg complexes;
D O I
10.1097/00042737-200012020-00016
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A 61-year-old man had a liver resection for a bilobar mass thought to be, by imaging techniques, an hepatocellular carcinoma. He had been treated for the last 12 years by venesections for genetic haemochromatosis complicated by well-compensated cirrhosis, At surgery, prothrombin time and platelet count were normal, as was a-fetoprotein. On the resected specimen, the non-tumoral liver was not cirrhotic; septal fibrosis was present as well as mild iron overload and numerous Von Meyenburg complexes. The bilobar tumour was composed of two different parts: one was a cholangiocarcinoma arising from Von Meyenburg complexes, the other was a moderately differentiated hepatocellular carcinoma with a partially invaded capsule. The two tumours, in close proximity, did not communicate. This observation raises three questions: the relative risk of primary liver cancer including both hepatocellular carcinoma and cholangiocarcinoma in haemochromatosis without cirrhosis; the development of cholangiocarcinoma from Von Meyenburg complexes; the reversibility of cirrhosis in treated patients. Eur J Gastroenterol Hepatol 12:233-237 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:233 / 237
页数:5
相关论文
共 15 条
[1]   Premalignant lesions and hepatocellular carcinoma in a non-cirrhotic alcoholic patient with iron overload and normal transferrin saturation [J].
Blanc, JF ;
De Ledinghen, V ;
Trimoulet, P ;
Le Bail, B ;
Bernard, PH ;
Saric, J ;
Balabaud, C ;
Bioulac-Sage, P .
JOURNAL OF HEPATOLOGY, 1999, 30 (02) :325-329
[2]   PRIMARY HEPATOCELLULAR-CARCINOMA IN IDIOPATHIC HEMOCHROMATOSIS AFTER REVERSAL OF CIRRHOSIS [J].
BLUMBERG, RS ;
CHOPRA, S ;
IBRAHIM, R ;
CRAWFORD, J ;
FARRAYE, FA ;
ZELDIS, JB ;
BERMAN, MD .
GASTROENTEROLOGY, 1988, 95 (05) :1399-1402
[3]  
CALLEA F, 1993, J SURG ONCOL, P131
[4]  
CHEN KTK, 1981, ARCH PATHOL LAB MED, V105, P294
[5]   PRIMARY LIVER-CANCER IN GENETIC HEMOCHROMATOSIS - A CLINICAL, PATHOLOGICAL, AND PATHOGENETIC STUDY OF 54 CASES [J].
DEUGNIER, YM ;
GUYADER, D ;
CRANTOCK, L ;
LOPEZ, JM ;
TURLIN, B ;
YAOUANQ, J ;
JOUANOLLE, H ;
CAMPION, JP ;
LAUNOIS, B ;
HALLIDAY, JW ;
POWELL, LW ;
BRISSOT, P .
GASTROENTEROLOGY, 1993, 104 (01) :228-234
[6]  
Deugnier Yves, 1998, Journal of Hepatology, V28, P21, DOI 10.1016/S0168-8278(98)80371-1
[7]   Reversibility of hepatic fibrosis in autoimmune hepatitis [J].
Dufour, JF ;
DeLellis, R ;
Kaplan, MM .
ANNALS OF INTERNAL MEDICINE, 1997, 127 (11) :981-985
[8]  
Harrison LE, 1998, BRIT J SURG, V85, P1068
[9]  
Kowdley K V, 1995, Liver Transpl Surg, V1, P237, DOI 10.1002/lt.500010408
[10]   Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic liver explants [J].
LeBail, B ;
Bernard, PH ;
Carles, J ;
Balabaud, C ;
BioulacSage, P .
JOURNAL OF HEPATOLOGY, 1997, 27 (05) :835-842